FRCPath Haem Part 1 MCQ-Oncology

A 67yr-old pt with intermediate-2 risk Myelofibrosis is treated with JAK Inhibitor. After 8 wks he develops confusion, ataxia, and ophthalmoplegia. Likely cause

• Ruxolitinib
• Momelotinib
• Pacritinib
• Fedratinib

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now